Please login to the form below

Not currently logged in
Email:
Password:

Vetter

This page shows the latest Vetter news and features for those working in and with pharma, biotech and healthcare.

GSK files immune deficiency gene therapy in Europe

GSK files immune deficiency gene therapy in Europe

A variant of the genetic disorder is known as bubble boy disease, after SCID patient David Vetter who spent much of his short life in a sterile chamber and died as

Latest news

More from news
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

  • Vetter names Oliver Albrecht as managing director Vetter names Oliver Albrecht as managing director

    Vetter names Oliver Albrecht as managing director. He has over 20 years of industry experience. ... compliance. Udo J Vetter, Vetter chairman of the advisory board, commented: “ Oliver's vast experience in a variety of industries, combined with his

More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics